Mitsubishi UFJ Asset Management’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
Other funds holding AXDX
GAM
OIM
BC
CC
CIA
BAM
Mitsubishi UFJ Asset Management's AXDX Position: Q2 2022 in Review
Mitsubishi UFJ Asset Management sold out of Accelerate Diagnostics (AXDX) in Q2 2022, closing a stake of 7,687 shares — an estimated $111K sold.
Mitsubishi UFJ Asset Management first reported a position in AXDX in Q3 2018 and held it in 15 quarters. The position peaked at $552K in Q2 2020. 74 funds tracked by Wall St. Rank hold AXDX as of Q2 2022.
- Mitsubishi UFJ Asset Management reported no remaining Accelerate Diagnostics position as of Q2 2022 after selling out during the quarter.
- Mitsubishi UFJ Asset Management sold 7,687 Accelerate Diagnostics shares in Q2 2022, an estimated $111K.
- Mitsubishi UFJ Asset Management first reported a position in Accelerate Diagnostics in Q3 2018 and held it in 15 quarters.
- Mitsubishi UFJ Asset Management's Accelerate Diagnostics position peaked at $552K in Q2 2020.
- 74 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2022.
Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2022, filed 4 Aug 2022.